• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Are Avocados Linked to Lower Risk of Heart Disease?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Avocados contain monounsaturated fats (MUFA) and polyunsaturated fats which are linked to improved health outcomes and lower risk of cardiovascular disease (CVD)
  • Pacheco et al. (Journal of the American Heart Association, 2022) examined the association between avocado consumption with total CVD, coronary heart disease, and stroke

METHODS:

  • Prospective cohort study (1986 to 2016)
    • Data came from
      • NHS (Nurses’ Health Study)
      • HPFS (Health Professionals Follow-up Study
  • Population
    • Women (from the NHS) and men (from the HPFS) free of cancer, coronary heart disease, and stroke at baseline
  • Exposure
    • Avocado intake, assessed using validated food frequency questionnaires at baseline and then every 4 years
  • Study design
    • Cox proportional hazards regressions were used to estimate hazard ratios
    • Adjustment was for lifestyle and other dietary factors
  • Primary outcome
    • Incident cases of total CVD
      • Defined as the composite of fatal coronary heart disease, nonfatal myocardial infarction, and fatal and nonfatal stroke
  • Secondary outcomes
    • Total coronary heart disease
    • Total stroke

RESULTS:

  • 68,786 women | 41,701 men
  • Over the 30-year follow-up there were
    • Incident cases of CVS: 14,274
    • Coronary heart disease events: 9185
    • Strokes: 5290
  • Compared with avocado non-consumers, those with a higher avocado intake (≥2 servings/week) had a lower risk of
    • CVD
      • Pooled hazard ratio (HR) 0.84 (95% CI, 0.75 to 0.95)
    • Coronary heart disease
      • Pooled HR 0.79 (95% CI, 0.68 to 0.91)
  • There were no significant associations between avocado consumption and stroke
  • For each half serving/day increase in avocado intake
    • Pooled HR for CVD was 0.80 (95% CI, 0.71 to 0.91)
  • Replacing half a serving/day of margarine, butter, egg, yogurt, cheese, or processed meats with the equivalent amount of avocado was associated with a 16% to 22% lower risk of CVD

CONCLUSION:

  • Higher levels of avocado consumption was associated with a 16% lower risk of CVD and a 21% lower risk of coronary heart disease
  • The authors suggest that replacing certain foods with avocado may reduce the risk of heart disease

Learn More – Primary Sources:

Avocado Consumption and Risk of Cardiovascular Disease in US Adults

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Could Plant-Based Diets Help Prevent Type 2 Diabetes?
Is There A Link Between Midlife Dietary Pattern and Later Cognitive Decline?
Does the Type of Dietary Fat Affect Mortality and Heart Disease in Individuals with Type 2 Diabetes?
Does Eating a Mediterranean Diet Reduce Risk of Stroke in Both Men and Women?
More Evidence on Whether Eating Nuts Is Associated with Cardiovascular Disease

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site